2022 ESG Performance Highlights

2022 ESG performance highlights Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. With commercial representation in more than 130 countries and 45,000 employees around the world, we understand that our impact as a health care company extends to how we operate our business and care for the world around us. Our ESG performance in 2022 Environment 20% decrease in global 71% of all Boston Scientific real estate (including commercial, leased energy intensity since 2017 and owned) is independently certified for energy efficiency by industry-leading bodies such as LEED for design and ISO 50001:2018 for building operations, representing 6+ million square feet 76% renewable electricity, 40% of energy from Remained on track for on track for our goal of renewable sources, on track carbon neutrality (scope 1 and 2) in all our 1,2 1 100% by 2024 for our goal of 90% by 2027 manufacturing and key distribution sites by 2030 SBTi approval Net-zero and greenhouse gas emission reduction targets approved by the Science Based Targets initiative (SBTi) Note: All data as of December 31, 2022 unless otherwise specified. 1 Inclusive of all manufacturing and key distribution sites only. 2 Purchased electricity matched with electricity from renewable sources.